Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sodium/glucose cotransporter 2 (SGLT2) (Homo sapiens (Human)) | BDBM254941![]() (US10294259, Compound Table 3.2 | US9505734, I-D1-6) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.670 | n/a | n/a | n/a | n/a | n/a | n/a |
Tianjin Institute of Pharmaceutical Research US Patent | Assay Description IC50 values of inhibition of some compounds described in the present invention and related compounds on SGLT2 and SGLT1 are determined according to t... | US Patent US10294259 (2019) BindingDB Entry DOI: 10.7270/Q2QC05V6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium/glucose cotransporter 2 (SGLT2) (Homo sapiens (Human)) | BDBM388440![]() (US10294259, Compound Table 3.1) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Tianjin Institute of Pharmaceutical Research US Patent | Assay Description IC50 values of inhibition of some compounds described in the present invention and related compounds on SGLT2 and SGLT1 are determined according to t... | US Patent US10294259 (2019) BindingDB Entry DOI: 10.7270/Q2QC05V6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium/glucose cotransporter 2 (SGLT2) (Homo sapiens (Human)) | BDBM388442![]() (US10294259, Compound Table 3.3) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Tianjin Institute of Pharmaceutical Research US Patent | Assay Description IC50 values of inhibition of some compounds described in the present invention and related compounds on SGLT2 and SGLT1 are determined according to t... | US Patent US10294259 (2019) BindingDB Entry DOI: 10.7270/Q2QC05V6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium/glucose cotransporter 1 (SGLT1) (Homo sapiens (Human)) | BDBM388440![]() (US10294259, Compound Table 3.1) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 86 | n/a | n/a | n/a | n/a | n/a | n/a |
Tianjin Institute of Pharmaceutical Research US Patent | Assay Description IC50 values of inhibition of some compounds described in the present invention and related compounds on SGLT2 and SGLT1 are determined according to t... | US Patent US10294259 (2019) BindingDB Entry DOI: 10.7270/Q2QC05V6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium/glucose cotransporter 1 (SGLT1) (Homo sapiens (Human)) | BDBM388442![]() (US10294259, Compound Table 3.3) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 187 | n/a | n/a | n/a | n/a | n/a | n/a |
Tianjin Institute of Pharmaceutical Research US Patent | Assay Description IC50 values of inhibition of some compounds described in the present invention and related compounds on SGLT2 and SGLT1 are determined according to t... | US Patent US10294259 (2019) BindingDB Entry DOI: 10.7270/Q2QC05V6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Sodium/glucose cotransporter 1 (SGLT1) (Homo sapiens (Human)) | BDBM254941![]() (US10294259, Compound Table 3.2 | US9505734, I-D1-6) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 251 | n/a | n/a | n/a | n/a | n/a | n/a |
Tianjin Institute of Pharmaceutical Research US Patent | Assay Description IC50 values of inhibition of some compounds described in the present invention and related compounds on SGLT2 and SGLT1 are determined according to t... | US Patent US10294259 (2019) BindingDB Entry DOI: 10.7270/Q2QC05V6 | |||||||||||
More data for this Ligand-Target Pair |